| 2 min read
Register for free to listen to this article
Listen with Speechify
0:00
2:00
ATHENS, Greece—The successful birth of the first healthy baby through the Maternal Spindle Transfer method – implemented for the first time by Greece’s Institute of Life and Spain’s Embryotools – is a global first, offering the potential to preserve the mother’s genetic material. The method was implemented by Institute of Life IVF Center and Embryotools in order to address fertility issues associated with multiple in vitro fertilization (IVF) failures caused by cytoplasmic dysfunction of the oocytes, or by rare mitochondrial genetic diseases.
 
The 6.5 pound baby boy was born at 7:46 a.m. today, April 9, 2019, to a 32-year-old Greek woman with a history of multiple IVF failures and poor oocyte quality. The mother and infant are both in good health.
 
“Today, for the first time in the world, a woman’s inalienable right to become a mother with her own genetic material became a reality. As Greek scientists, we are very proud to announce an international innovation in assisted reproduction, and we are now in a position to make it possible for women with multiple IVF failures or rare mitochondrial genetic diseases to have a healthy child,” said Dr. Panagiotis Psathas, president of the Institute of Life. “At the Institute of Life, our commitment is to continue to help even more couples facing fertility issues to have children with their own DNA, without [needing] egg donors.”
 
The Maternal Spindle Transfer method, which was developed after five years of basic research at Embryotools in Spain and two and half years of clinical validation at the Institute of Life’s laboratory in Greece, involves mitochondrial replacement in human oocytes, fully preserving the genetic material of the woman who wants to reproduce. In this way, specialists can overcome the problems of women with fertility issues and multiple IVF failures caused by cytoplasmic dysfunctions of their oocytes, or failures caused by rare mitochondrial genetic diseases. The clinical implementation of the Maternal Spindle Transfer method is carried out under licensing and supervision of the Greek National Authority of Assisted Reproduction.
 
Dr. Nuno Costa-Borges, co-founder of Embryotools and scientific collaborator of the Institute of Life, noted that “The completely successful and safe implementation of the Maternal Spindle Transfer method – for the first time in medical history – is a revolution in assisted reproduction. I want to thank and congratulate the whole European team that made it possible, and especially the Institute of Life IVF Center. Our excellent collaboration and this exceptional result will help countless women to realize their dream of becoming mothers with their own genetic material.”

Related Topics

Loading Next Article...
Loading Next Article...
Subscribe to Newsletter

Subscribe to our eNewsletters

Stay connected with all of the latest from Drug Discovery News.

Subscribe

Sponsored

Reliable fluid biomarkers strategies for clinical neuroscience research

Reliable fluid biomarkers strategies for clinical neuroscience research

Explore how validated fluid biomarker assays advance clinical research for neurological diseases.
A group of blue capsules is scattered on a bright yellow surface, with one capsule opened to reveal white powder inside.

Understanding drug impurities: types, sources, and analytical strategies

Unseen and often unexpected, drug impurities can slip in at every drug development stage, making their detection and control essential.
Laboratorian with a white coat and blue gloves pipettes green liquid into a beaker with multicolored liquids in beakers and tubes in the blue-tinged, sterile laboratory background.

Discovering cutting-edge nitrosamine analysis in pharmaceuticals

New tools help researchers detect and manage harmful nitrosamine impurities in drugs such as monoclonal antibodies.
Drug Discovery News March 2025 Issue
Latest IssueVolume 21 • Issue 1 • March 2025

March 2025

March 2025 Issue

Explore this issue